Recent news on Rasagiline

Alzheimer's and Parkinson's sufferers receive boost from Israeli ...  -  May 3, 2007
Israel 21C,Marta Weinstock-Rosin - focusing on a novel drug called ladostigil and which combines tbe strength of Exelon with Rasagiline.

Earnings shoot up at Denmark's Lundbeck as Lexapro sales soar  -  May 10, 2007
Pharma Times (subscription),The Alzheimer's disease drug Ebixa (memantine) climbed 26% to 391 million kroner and two of the firm's newer products - Azilect (rasagiline) for Parkinson's

7 Companies Searching to Cure Parkinson's  -  Apr 25, 2007
Seeking Alpha,It received approval from the US Food and Drug Administration for AZILECT® (rasagiline tablets) as a treatment for Parkinson's disease.

Medical Edge -- Gold-standard treatment for Parkinson's patients  -  27 Mar 2007
Post-Bulletin,The drug approved last May -- rasagiline (Azilect) -- is an inhibitor of monoamine oxidase B, an enzyme that metabolizes dopamine.

Lundbeck profits down but Cipralex sales continue to soar  -  Mar 8, 2007
Pharma Times (subscription),The firm's two products approved in 2005 - Azilect (rasagiline) for Parkinson's disease and Serdolect (sertindole) for schizophrenia - contributed 71

Teva shares rise on the promise of a strong 2007 and 2008  -  Feb 14, 2007
Pharma Times (subscription),...quarter with sales up 17% to $378 million, while the firm's recently-launched Parkinson's disease drug Azilect (rasagiline) brought in $19 million.

Clal Finance: Teva’s Q4 results a little disappointing  -  Feb 13, 2007
Globes,On the other hand, Azilect (rasagiline) is picking up speed and will reach $19 million. “Financially, Teva is in good shape. 2007 is a done deal,

Lundbeck sets up Israeli drug discovery task force  -  Feb 8, 2007
Globes,...with Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) on the development of Azilect (rasagiline) for the treatment of Parkinson’s disease.

Largest Disease Modification Trial for Parkinson's Disease ...  -  Dec 22, 2006
PharmaLive.com (press release),AZILECT(R) (rasagiline tablets) is indicated for the treatment of the signs and symptoms of Parkinson's disease (PD) both as initial therapy alone and to be

Largest Disease Modification Trial For Parkinson's Disease ...  -  Dec 24, 2006
Medical News Today (press release),...study is evaluating approximately 1,200 recently diagnosed patients worldwide to determine if treatment with once-daily AZILECT(R) (rasagiline tablets) can ...

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional